David H. Miller, M.D.

Cardiovascular Disease
David Miller

Dr. Miller has been a member of the clinical faculty at Cornell since 1981, providing inpatient and outpatient care to patients with cardiac disorders. His administrative duties include serving as Director of the Cardiac Care Unit (a 20-bed unit for cardiac patients requiring intensive care) as well as serving as a member of the hospital's Committee on Medical Ethics. His research interests include the study of treatments of patients suffering acute coronary syndromes.

M.D.- University of Virginia Medical School- 1976

Internship- Internal Medicine- The New York Hospital- 1977

Residency- Intenal Medicine- The New York Hospital- 1979

Fellow - Cardiology- The New York Hospital-CUMC- 1982

Insurances

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.

  • AETNA [HMO]
  • AETNA [PPO]
  • AETNA [Medicare]
  • Aetna - Weill Cornell [POS]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • CIGNA
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Insurance Plan of NY (HIP)
  • Health Plus - Amerigroup [CHP]
  • Health Plus - Amerigroup
  • Health Republic
  • Medicaid
  • Medicare
  • Medicare [Medicare]
  • Oscar
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Freedom]
  • POMCO
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care
  • United Health Care [Medicare]
  • United Health Care [Community Plan]
  • VNSNY CHOICE Medicare [Medicare]
  • VNSNY CHOICE Medicare [HMO]

Publications

Miller, D.H., and Borer, J.S.: Exercise Testing Early After Myocardial Infarction: Risks and Benefits.


American Journal of Medicine 72:427-438, 1982.



Miller, D.H., Eisenberg, R.R., Kligfield, P.D., Devereux, R.B., Casale, P.N., and Phillips, M.C.:


Electrocardiographic Recognition of Left Atrial Enlargement. Journal of Electrocardiology, 16:15-22, 1982.



Miller, D.H., and Borer, J.S.: The Cardiomyopathies: A Pathophysiologic Approach to Therapeutic Management. Archives of Internal Medicine 143:2157-2162, 1983.



Borer, J.S., Miller, D.H., Phillips, P., Moses, J.W., Goldberg H.L., Fisher J.: Prevention of Sudden Death: Selection of Patients at Risk, in SelectedTopics in Cardiology; Sudden Death. Raineri and Kellerman, ed. Plenum, London, 1983.



Miller, D.H., and Schreiber, T.L.: The Pharmacologic Management of Acute Myocardial Infarction, in Cardiovascular Therapeutics ?83, Supplement to Primary Cardiology, 1983.



Miller, D.H., and Schreiber, T.L.: Early Management of Acute Myocardial Infarction: Limitation of Infarct Size. Clinical Cardiology in Practice 1:4-11, 1984.



Devereux, R.B., Casale, P.N., Eisenberg, R.R., Miller, D.H., Kligfield, P.,: Electrocardiographic Detection of Left Ventricular Hypertrophy Using Echocardiographic Determination of Left Ventricular Mass as the Reference Standard. Comparison of Standard Criteria, Computer Diagnosis, and Physician Interpretation. Journal of the American College of Cardiology 3:82-87, 1984.



Devereux, R.B., Lutas, E.M., Casale, P.N., Kligfield, P., Eisenberg, R.R., Hammond, I.W., Miller, D.H., Reis, G., Alderman, M.H, Laragh, J.H.: Standardization of M-mode Echocardiographic Left Ventricular Anatomic Measurements. Journal of the American College of Cardiology 4:1222-30, 1984.



Ameisen, O., Okin, P.M., Devereux, R.B., Hochreiter, C., Miller, D.H., Zullo, M.J., Borer, J.S., and Kligfield, P.: Predictive Value and Limitations of ST/HR Slope. British Heart Journal 53:547-551, 1985.



Thrombolysis in Myocardial Infarction (TIMI) Trial Phase I Findings. The New England Journal of Medicine 312;932-936, 1985.



Casale, P.N., Devereux, R.B., Kligfield, P., Eisenberg, R.R., Miller, D.H., Chavdhary, B., and Phillips, M.C.: Electrocardiographic Detection of Left Ventricular Hypertension: Development and Prospective Validation of Improved Critera. Journal of the American College of Cardiology 6:572-80, 1985.



Hillis, L.D., borer, J., Braunwald, E., Chesebro, J.H, Cohen, L.S., Dalan, J., Dodge, H.T., Francis, C.K., Knatterud, G., Ludbrook, P., Markis, J.E., Mueller, H., Desvigne-Nichens, P., Passamani, E.R., Powers, E.R., Rao, A.K., Roberts, R., Roberts, W.C., Ross, A., Ryan, T.J., Sobel, B.E., Williams, D.O., Zaret, B.L., and Co-Investigators: High Dose Intravenous Steptokinase for Acute Myocardial Infarction, Preliminary Results of a Multicenter Trial. Journal of the American College of Cardiology 6:957-962, 1985.



Schreiber, T.L., Miller, D.H., Borer, J.S., and Silvasi, D.: Randomized Double Blind Trial of Intravenous Streptokinase for Acute Myocardial Infarction. American Journal of Cardiology 58:47-52, 1986.



Devereux, R.B, Casale, P.N., Kligfield, P., Eisenberg, R.R., Miller, D.H., Campo, E., and Alonso, D.R.: Performance of Primary and Derived M-Mode Echocardiographic Measurements for Detection of Left Ventricular Hypertrophy in Necropsied Subjects and in Patients with Systemic Hypertension, Mitral Regurgitation, and Dilated Cardiomyopathy. American Journal of Cardiology 57:1388-1393, 1986.



Ameisen, O., Kligfield, P., Okin, P., Miller, D.H., and Borer, J.S.: Effects of Recent and Remote Infarction on the Predictive Accuracy of the ST Segment/Heart Rate Slope. Journal of the American college of Cardiology 8:267-273, 1986.



Williams, D.O., Borer, J., Braunwald, E., Chesebro, J.H., Cohen, L.S., Dalan J., Dodge, H.T., Francis, C.K., Knatterud, G., Ludbrook, P., Markis, J.E., Mueller, H., Desvignes-Nickens, P., Passamani, E.R., Powers, E.R., Rao, A.K., Roberts, R., Ross, A., Ryan, T.J., Sobel, B.E., Winneford, M., Zaret, B. and Co-Investigators: Intravenous Recombinant Tissue-Type Plasminogen Activators in Patients with Acute Myocardial Infarction: A Report from the NHLBI Thrombolysis in Myocardial Infarction Trial. Circulation 73:338-346, 1986.



Miller, D.H., Kligfield, P., Schreiber, T.L., and borer, J.S.: The Relationship of Prior Myocardial Infaction to False Positive Electyrocardiographic Diagnosis of Acute Injury In Patients with Chest Pain. Archives of Internal Medicine 1147:257-261, 1987.



Borer, J.S., Miller, D.H., Schreiber, T., Charash, B., and Gerling, B.: Radionuclide Cineangiography in Acute Myocardial Infarction (TIMI Phase I) Trial. Circulation 75:817-829, 1987.



Passamani,E., Hdges, M., Herman, M., Grose, R., Chaitman, B., Rogers, W., Forman, S., Terrin, M., Knatterud, G., Robertson, T., and Braunwald, E. for the TIMI Investigators: The Thrombolysis in Myocardial Infarction (TIMI) Phase II Pilot Study: Tissue Plasminogen Activator Followed by Percutaneous Transluminal Coronary Angioplasty.. Journal of the American College of Cardiology 10:51B-64B, 1987.



Guidelines on the Termination of Life-Sustaining Treatment and the Care of the Dying, The Hastings Center, Briarcliff Manor, New York, 1987.



Miller, D.H.: ?Commentary ? The Patient as Stranger ? The Case of Mr. Jaworski?, in Casebook on the Termination of Life-Sustaining Treatment and the Care of the Dying. Indiana University Press 42-45, 1988.



Rao, A.K., Pratt, C., Berke, A., Jaffe, A., Ockene, I., Schreiber, T.L., Bell, W.R., Knatterud, G., Robertson, T.L., Terrin, M.I. for the TIMI Investigators: The Throbolysis in Myocardial Infarction (TIMI) Trial, Phase I: Hemorrhagic Manifestations and Changes in Fibrinogen and Fibrinolytic System. Journal of the American College of Cardiology 11:1-11, 1988.



Mueller, H.S., Rao, A.K., Forman, S.A., and the TIMI Investigators: Thrombolysis in Myocardial Infarction (TIMI) Trial: Comparative Studies of Coronary Reperfusion and Systemic Fibrinogenolysis with Two Forms of Recombinant Tissue-Type Plasminogen Activator. Journal of The American College of Cardiology 10:479-490, 1987.





Williams, D.O., Ruocco, N.A., Forman, S., and the TIMI Investigators: Coronary Angioplasty after Recombinant Tissue-Type Plasminogen Activator in Acute Myocardial Infarction. A Report from the Thrombolysis in Myocardial Infarction (TIMI) Trial. Journal of the American College of Cardiology 10:45B-50B, 1987.



Dalen, J.E., Gore, J.M., Braunwald, E., Borer, J., Goldberg, R.J., Passamani, E.R., Forman, S., Knatterud, G., and the TIMI Investigators: Six- and Twelve-Month Follow-Up of the Phase I Thrombolysis in Myocardial Infarction (TIMI) Trial. American Journal of Cardiology 62:179-185, 1988.



Amchin, J., Perry, S., Manevitz, A., Cella, D., and Miller, D.H.: Interview Assessment of Critically Ill Patients Regarding Resuscitation Decisions: A Case Study in Ethics Research. General Hospital Psychiatry 11:103-108, 1989.



Kalb, P.E., and Miller, D.H.: Utilization Strategies for Intensive Care Units. Journal of the American Medical Association 261:2389-2395, 1989.



The TIMI Study Group: Comparison of Invasive and Conservative Strategies Following Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) II Trial. New England Journal Of Medicine 320:242-256, 1989.



Schreiber, T.L., Fisher, J., Mangla, A., Miller, D.H.: Severe ?Silent? Mitral Regurgitation ? A Potentially Reversible Cause of Refractory Heart Failure. Chest 96:242-256, 1989.



Schreiber, T.L., Miller, D.H., and Zola, B.: Management of Myocardial Infarction Shock: Current Status. American Heart Journal 117:435-443, 1989.



Wackers, F.J., Terrin, M.L., Kayden, D.S., Knatterud, G., Forman, S., Braunwald, E., Zaret, B.L., and the TIMI Investigators: Quantitative Radionuclide Assessment of Regional Ventricular Function After Thrombolytic Therapy for Acute Myocardial Infarction: Results of Phase I Thrombolysis in Myocardial Infarction (TIMI) Trail. Journal of the American College of Cardiology 13, 998-1005, 1989.



Rogers, W.J., Bourge, R.C., Papapietro, S.E., Wackers, Fr. J.Th., Zaret, B.L., Forman, S., Dodge, H.T., Robertson, T.G. Passamani,E.R. and Braunwald, E. for the TIMI Investigators: Variables Predictive of Good Functional Outcome Following



David H. Miller, MD





Thrombolytic Therapy in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Pilot Study. American Journal of Cardiology 63:503-512, 1989.



Kalb, P.E., and Miller, D.H.: Utilization Strategies for Intensive Care Units, Letter. Journal of the American Medical Association 262: 1468, 1989.



Miller, D.H.: Must Consent Always Be Obtained Before Issuing a DNR Order? Decisions Near the End of Life, Education Development Center, Newton Mass., Module 1, 4, 1989.



Schreiber, T.L., Macina, G. McNulty, A., Bunnell, P., Kikel, M., Miller, D.H., Devereux, R.B., Tenney, R., Cowley, M. and Zola, B.: Urokinase Plus Heparin Versus Aspirin in Unstable Angina and non-Q Wave Myocardial Infarction. American Journal of Cardiology 64:840-844, 1989.



Chaitman, B.R., Thomson, B., Wittry, M.D., Stump, D., Hamilton, W.P., Hillis, L.D., Dwyer, J.G., Solomon, R.E., and Knatterud, G.L. for the TIMI Investigators: The Use of Tissue-type Plasminogen Activator for Acute Myocardial Infarction in the Elderly: Results from Thrombolysis in Myocardial Infarction Phase I, Open Label Studies and the Thrombolysis in Myocardial Infarction Phase II Pilot Study. Journal of the American College of Cardiology 14:1159-65, 1989.



Schreiber, T.L., Miller, D.H., Silvasi, D., McNulty, A., and Zola, B.E.: Superiority of Warfarin over Aspirin Long Term After Thrombolytic Therapy for Acute Myocardial Infarction. American Heart Journal 119:1238-1244, 1990.



Miller, D.H.: ?Make Me Live?. The Hasting?s Center Report, 20:42-44, 1990.



Chaitman, B.R., Thompson, B.W., Kern, M.J., Vandormael, M.G., Cohen, M.D., Ruocco, N.A., Solomon, R.E., and Braunwald, E. for the TIMI Investigators: Tissue Plasminogen Activator Followed by Percutaneous Transluminal Coronary Angioplasty: One-Year TIMI Phase II Pilot Results. American Heart Journal 119:213-23, 1990.



Gert, S.D., Kalan, J.M., Kragel, A.H., Roberts, W.C., Braunwald, E., and the TIMI Investigators: Cardiac Morphologic Findings in Patients With Acute Myocardial Infarction Treated With Recombinant Tissue Plasminogen Activator. American Journal of Cardiology 65:953-961, 1990.



Hillis, L.D., Forman, S., Braunwald, E. and the Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators: Risk Stratification Before Thrombolytic Therapy in Patients With Acute Myocardial Infarction. Journal of the American College of Cardiology 16:313-315, 1990.



Feit, F., Mueler, H.S., Braunwald E., Ross, R., Hodges, M., Herman, M.V., Knatterud, G.L., and the TIMI Research Group: Thrombolysis in Myocardial Infarction Treated With Recombinant Tissue Plasminogen Activator. American Journal of Cardiology 616:1529-1534, 1990.



Rogers, W.J., Babb, J.D., Baim, D.S., Chesebro, J.H., Gore, J.M., Roberts, R., Williams, D.O., Frederick, M., Passamani, E.R., and Graunwald, E. for the TIMI II Investigators: Selective Versus Routine Pre-discharge Coronary Arteriography Following Therapy With Rt-PA, Heparin and Aspirin for Acute Myocardial Infarction. Journal of the American College of Cardiology 17:1007-1016, 1991.



Gore, J.M., Sloan, M., Price, T.R., Randall, A.M.Y., Bovill, E., Collen, D., Forman, S., Knatterud, G.L., Sopko, G., Terrin, M.L., and the TIMI Investigators: Intracerebral Hemorrhage, Cerebral Infarction, and Subdural Hematoma Following Acute Myocardial Infarction and Thrombolytic Therapy in the Thrombolysis in Myocardial Infarction Study (TIMI) II-B Study. Circulation 83:422-437, 1991.



Bovill,, E.G., Terrin, M.L., Stump, D.C., Berke, A.D., Frederick, M., Collen, D., Feit, F., Gore, J.M., Hillis, L.D., Lambrow, C.T., Leiboff, R., Mann, K.G., Markis, J.E., Pratt, C.M., Sharkey, S.W., Sopko, G., Tracey, R.P., Chesebro, J.H. for the TIMI Investigators: Hemorrhagic Events During Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction. Annals of Internal Medicine 115:256-265, 1991.



Mueller, H.S., Cohen, L.S., Braunwald, E., Forman, S., Feit, F., Ross, A., Schweiger, M., Cabin, H., Davison, R., Miller, D.H., Solomon, K., Knattered, G.L., for the TIMI Investigators: Predictors of Early Morbidity and Mortality Following Thromboytic Therapy of Acute Myocardial Infarction. Analyses of Patient Subgroups in the Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase II Trial. Circulation 85:1254-1264, 1992



Zaret, B.L., Wacker, Frans J.Th., Terrin, M.L., Ross, R., Weiss, M., Slater, J., Morrison, J., Bourge, R.C., Passamni, E., Knatterud, G., and Braunwald, E. for the TIMI Investigators: Assessment of Global and Regional Left Ventricular Thrombolysis in Myocardial Infarction (TIMI) II Study. American Journal of Cardiology 69:1-9, 1992.





Ulin, R.J., Zola, B.E., Miller, D.H.: Use of Tissue Plasminogen Activator in Elderly Patients With Acute Myocardial Infarction. American Journal of Geriatric Cardiology 2:32-39, 1993.



Kleiman, N.S., Terrin, M., Mueller, H., Cheitman, B., Roberts, R., Knatterud, G.L., Solomon, R., McMahon, R.P., Braunwald, E., and the TIMI Investigators: Mechanisms of Early Death Despite Thrombolytic Therapy: Experience From the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study. American Journal of Cardiology 71:131-138, 1993.



Lehmann, K.G., Francis, C.K., Sheehan, F.H., Dodge, H.T., and the TIMI Study Group: Effect of Thrombolysis on Acute Mitral Regurgitation During Evolving Myocardial Infarction: Experience from the Thrombolysis in Myocardial Infarction (TIMI) Trial. Journal of the American College of Cardiology 22:1763-72, 1993.



Miller, D.H.: The Rationing of Intensive Care. Critical Care Clinics 10:135-143, 1994.



Hochman, J.., Boland, J., Slepper, L., Porway, M., Brinker, J., Col, J., Jacobs, A., Slater, J., Miller, D.H., Wasserman, H., Menegus, M., Talley, D., McKinlay, S., Sanborn, T., LeJemtel, T., and the SHOCK Registry Investigators. Current Spectrum of Cardiogenic Shock and of Early Revascularization on Mortality: Results of An International Registry. Circulation 91:873-881, 1995.



Gersh, B.J., Chesebro, J.H., Braunwald, E., Lambrew, C., Passamani, E., Solomon, R.E., Ross, A.M., Ross, R., Terrin, M.L., Knatterud, G.L., and the TIMI II Investigators: Coronary Artery Bypass Graft Surgery After Thrombolytic Therapy in The Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II). Journal of American College of Cardiology 25:395-402, 1995.



Miller, D.H., and Funk, M.E.: Cardiology in the Elderly (Review). Journal of the American Medical Associates 273: 1395, 1995.



Aguirre, F.V., Younis, L.T., Chaitman, B.R., Ross, A.M., McMahon, R.P., Kern, M.J., Berger, P.B., Sopko, G., Rogers, W.J., Shaw, L., Knatterud, G., Braunwald, E., for the TIMI II Investigators: Early and 1-year clinical Outcomes of Patients? Evolving Non-Q-Wave versus Q-Wave Myocardial Infarction After Thrombolysis: Results from the TIMI II Study. Circulation 91: 2541-2548, 1995.



Sloan, M.A., Price, T.R., Petito, C.K., Randall, AMY, Solomon, R.E., Terrin, M.L., Gore, J., Collen, D., Kleiman, N., Feit, F., Babb, J., Herman, M., Roberts, W.C., Sopko, G., Bovill, E., Forman, S., Knatterud, G., for the TIMI Investigators: Clinical Features and Pathogenesis of Intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: The TIMI II Pilot and Randomized Trial Combined Experience. Neurology 45:649-658, 1995.



Zaret, B.L., Wackers, F.Th., Terrin, M.L., Forman, S.A., Williams, D.O., Knatterud, G.L., Braunwald, E. for the TIMI Study Group: Value of Radionuclide Rest and Exercise Left Ventricular Ejection Fraction in Assessing Survival of Patients After Thrombolytic Therapy for Acute Myocardial Iunfarction: Results of the TIMI II Study. Journal of the American College of Cardiology 26:73-79, 1995



Mueller, H.S., Forman, S.A., Menegus, M.A., Cohen L.S., Knatterud, G.L, Braunwald, E., for the TIMI II Investigators: Prognostic Significance of Nonfatal Reinfarction during 3 year follow-up: Results of TIMI II. Journal of the American College of Cardiology; 26:900-7, 1995.



Coumadin Aspirin Reinfarction Study (CARS) Investigators. Randomized Double-Blind Trial of Fixed Low-Dose Warfarin with Aspirin after Myocardial Infarction. The Lancet: 350:389-396, 1997.



Hochman, J.S., Sleeper, L.A., Godrey, E., McKinky, S.M., Sanborn, T., Col, J., LeJemtel, T., for the Shock Study Group: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock: An International Randomized Trial of Emergency PTCA/CABG ? Trial Design. American Heart Journal137:313-321, 1999.




Hochman, J.S., Sleeper, L.A., Webb, J.G., Sanborn, T.A., White, H.D., Talley, J.D., Buller, C.E., Jacobs, R.K., Slater, J.N, Col, J., McKinlay, S.M., and LeJemtel, T.H., for the SHOCK Investigators: Early Revascularization

Honors and Awards

Alpha Omega Alpha Honor Society

American College of Cardiology, Fellow

American College of Physicians

American Heart Association, Council on

Clinical Cardiology